Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DRTS | US
0.22
3.03%
Healthcare
Biotechnology
30/06/2024
17/03/2026
7.47
7.30
7.64
7.28
Alpha Tau Medical Ltd. a clinical-stage oncology therapeutics company engages in research development and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin oral pancreatic prostate and breast cancers; and preclinical studies for brain hepatic cell carcinoma glioblastoma multiforme lung cancer and others. The company was incorporated in 2015 and is headquartered in Jerusalem Israel.
View LessPositive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
72.7%1 month
76.2%3 months
83.9%6 months
77.0%-
-
2.13
0.17
0.13
-4.77
-
-
-35.22M
522.33M
522.33M
-
-
-
-
-33.17
1.60
0.08
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.54
Range1M
2.50
Range3M
3.88
Rel. volume
0.81
Price X volume
1.83M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Esperion Therapeutics Inc | ESPR | Biotechnology | 2.71 | 550.02M | 0.74% | n/a | -161.71% |
| ZVRA | ZVRA | Biotechnology | 9.9 | 520.92M | 0.30% | n/a | 183.10% |
| Aviragen Therapeutics Inc | AVIR | Biotechnology | 6.13 | 517.51M | 1.32% | n/a | 0.43% |
| Kamada Ltd | KMDA | Biotechnology | 8.89 | 510.99M | -0.11% | 20.15 | 3.41% |
| Bright Minds Biosciences Inc. Common Stock | DRUG | Biotechnology | 72.13 | 507.77M | -1.48% | n/a | 0.23% |
| Vanda Pharmaceuticals Inc | VNDA | Biotechnology | 8.6 | 501.29M | -2.38% | n/a | 1.55% |
| Kezar Life Sciences Inc | KZR | Biotechnology | 6.81 | 496.87M | -1.30% | n/a | 11.69% |
| Eton Pharmaceuticals Inc | ETON | Biotechnology | 18.92 | 488.82M | -0.47% | n/a | 36.23% |
| Prothena Corporation plc | PRTA | Biotechnology | 9 | 484.02M | -1.85% | n/a | 2.08% |
| Entrada Therapeutics Inc. Common Stock | TRDA | Biotechnology | 12.59 | 468.34M | -1.18% | 5.77 | 14.99% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Ennis Inc | EBF | Building Products & Equipment | 20.9 | 543.48M | -1.14% | 13.28 | 2.28% |
| Malibu Boats Inc | MBUU | Recreational Vehicles | 26.05 | 520.76M | 0.58% | n/a | 1.50% |
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 19.99 | 331.98M | 0.60% | 34.27 | 26.82% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.21 | 307.51M | -0.93% | n/a | 174.23% |
| Urban One Inc | UONEK | Broadcasting - Radio | 5.65 | 299.49M | -0.53% | n/a | 268.43% |
| Camping World Holdings Inc | CWH | Recreational Vehicles | 6.26 | 282.51M | 0.00% | n/a | 3644.76% |
| Marine Products Corporation | MPX | Recreational Vehicles | 7.14 | 247.88M | 0.14% | 13.23 | 0.00% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 14.45 | 161.23M | -2.82% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 8.6 | 138.09M | -0.06% | n/a | 286.96% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.26 | 101.97M | -0.16% | 9.09 | 39.79% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -4.77 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.13 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 83.89 | 72.80 | Par |
| Debt to Equity | 0.17 | -1.23 | Expensive |
| Debt to Assets | 0.13 | 0.25 | Cheaper |
| Market Cap | 522.33M | 3.66B | Emerging |